Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/14/2003WO2003066887A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
08/14/2003WO2003066885A2 Method for screening for compounds having hdac inhibitory activity
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066877A2 Compositions and methods relating to hepatic specific genes and proteins
08/14/2003WO2003066876A2 An apparatus and methods for using biological material to discriminate an agent
08/14/2003WO2003066849A2 Novel purified polypeptides from staphylococcus aureus
08/14/2003WO2003066848A1 Porcine fgl2
08/14/2003WO2003066845A2 Bacteriophage lysin
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066838A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
08/14/2003WO2003066834A2 Composition and method for modulating an inflammatory response
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066819A2 A novel artemis/dna-dependent protein kinase complex and methods of use thereof
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066811A2 Msrebps as modifiers of the srebp pathway and methods of use
08/14/2003WO2003066808A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
08/14/2003WO2003066807A2 Method of inhibiting pathogenicity of infectious agents
08/14/2003WO2003066802A2 Gene expression analysis using nicking agents
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066675A1 Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
08/14/2003WO2003066639A2 Methods for identifying targeting domains and methods and compositions comprising the same
08/14/2003WO2003066634A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003WO2003066529A1 Water treatment device
08/14/2003WO2003066257A1 Apparatus for machining composite material test specimens
08/14/2003WO2003066218A1 Device for analyzing a molecule using a fluid contacted with a support bearing a molecule
08/14/2003WO2003066212A2 Microarray synthesis instrument and method
08/14/2003WO2003066128A2 Autonomous, ambulatory analyte monitor or drug delivery device
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066080A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066043A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003WO2003066034A2 Use of compounds and compositions derived form olives for protecting cells against dna damage
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065979A2 Methods of diagnosis, monitoring and treatment of fertility
08/14/2003WO2003065978A2 Crystals and structures of a flavin mononucleotide binding protein (fmnbp)
08/14/2003WO2003065976A2 Microfluidics apparatus and methods of use therefor
08/14/2003WO2003065972A2 Methods for screening osteogenic compounds
08/14/2003WO2003065875A2 Method and test strips for the measurement of fat loss during weight loss programs
08/14/2003WO2003065873A2 Sga-1m, a cancer associated antigen, and uses thereof
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
08/14/2003WO2003039327A3 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
08/14/2003WO2003038423A3 Sensor assembly
08/14/2003WO2003038400A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394
08/14/2003WO2003034034A3 Automated system and method for processing multiple liquid-based specimens
08/14/2003WO2003033721A3 Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003031934A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003029924A3 Adaptive baseline algorithm for quantitative pcr
08/14/2003WO2003026395A3 Mo54 gene disruptions, compositions and methods related thereto
08/14/2003WO2003023365A3 Electrochemical sensor using intercalative, redox-active moieties
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003021228A3 Heteroaryl substituted benzothiazole dioxetanes
08/14/2003WO2003019145A3 Non-fluorescent quencher compounds and biomolecular assays
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003014303A3 Molecular interactions in cells
08/14/2003WO2003007705A8 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same
08/14/2003WO2003007293A8 Optical disc system and related detecting methods for analysis of microscopic structures
08/14/2003WO2003000845A3 Methods for detection of disease-associated antibodies in urine
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002095361A3 Identification of anti-protozoal agents
08/14/2003WO2002092849A3 Methods
08/14/2003WO2002082085A3 Conditional autoimmune reaction by natural autoantibodies
08/14/2003WO2002070020A9 Polymer precursors of radiolabeled compounds, and methods of making and using the same
08/14/2003WO2002068696A3 Methods for dna conjugation onto solid phase including related optical biodiscs and disc drive systems
08/14/2003WO2002066988A3 Phosphoprotein binding agents and methods of their use
08/14/2003WO2002062198A3 Methods for measuring stress in mammals
08/14/2003WO2002059610A3 Lamin alpha 4 subunit as a diagnostic indicator of malignant tumors
08/14/2003WO2002059344A3 Gpr54 g protein-coupled receptor
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057795A3 Methods of diagnosis and treatment of osteoporosis
08/14/2003WO2002057479A3 Primers and methods for the detection and discrimination of nucleic acids
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002055735A3 Compositions and methods relating to prostate specific genes and proteins
08/14/2003WO2002055731A3 Dosage adjustement for antibiotics
08/14/2003WO2002055560A3 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
08/14/2003WO2002054079A3 Proteins, genes and their use for diagnosis and treatment of cardiac response
08/14/2003WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002048193A3 Camelidae antibody arrays
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002044427A3 Cell based triple readout assay systems for identifying compounds that effect transcription
08/14/2003WO2002036632A3 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides
08/14/2003WO2002029117A3 Methods and probes for detection and/or quantification of nucleic acid sequences
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002027034A3 Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents
08/14/2003WO2002024337A9 Multiple analyte assay device with sample integrity monitoring system
08/14/2003WO2002023153A3 Apparatus for the detection and measurement of particulates in molten metal
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002018660A3 Detection of varicella-zoster virus
1 ... 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 ... 3937